Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05994209 · ClinicalTrials.gov registry record · Phase 1
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
A Phase 1 study of Nicotine Use Disorder and Nicotine Vaping, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 189
- Enrollment target
- 1
- Study location
NCT05994209 is a Phase 1 study of Nicotine Use Disorder and Nicotine Vaping that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 189 participants, above the 76-participant average among 7 other Nicotine Use Disorder trials with a reported enrollment target (149% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05994209, a Phase 1 study of Nicotine Use Disorder and Nicotine Vaping, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 189 participants
- Enrollment target
- 1
- Study location
Study Summary
Use of vaping products (e.g., electronic nicotine delivery systems, e-cigarettes) has been increasing rapidly, particularly among teens and young adults. With limited information on the long-term effects of vaping products, health information about vaping has been somewhat unclear in regards to associated health risks. Teens and young adults may be reluctant to disclose their use of vaping products to parents or health providers and instead turn to social media to share and seek out information regarding vaping risks and cessation supports. Thus, our current proposal outlines the use of social media to identify teens and young adults socially networking about vaping, the use of an online chatbot screen to evaluate individual cessation support needs, and the use of a digital intervention system to support vaping cessation. The mobile intervention used in this study is based on a widely-used evidence-based mobile intervention for combustible smoking (i.e., quitSTART) and has been adapted for vaping and young adults to include an in-app chatbot to guide users to tailored content and to motivate and encourage their cessation efforts. We aim to integrate our social media recruitment and online screening approach to connect individuals with this mobile app intervention, and will conduct a randomized controlled trial to evaluate user engagement with and preliminary efficacy of the digital intervention on reducing vaping behaviors among teens and young adults.
Conditions Studied
Interventions
- DEVICE quitSTART Mobile Application
- BEHAVIORAL Chatbot Feature in quitSTART Mobile Application
Study Locations (1)
Missouri
- Washington University in St. Louis, School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2025-06-04 |
| Est. Completion | 2026-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05994209
The ClinicalTrials.gov registry entry for NCT05994209 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 189 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 76-participant average among 7 other Nicotine Use Disorder trials with a reported enrollment target (149% higher). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Nicotine Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which quitSTART Mobile Application is the first listed.
NCT05994209 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT05994209 about?
NCT05994209 is a clinical study titled "Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors". Use of vaping products (e.g., electronic nicotine delivery systems, e-cigarettes) has been increasing rapidly, particularly among teens and young adults. With limited information on the long-term effects of vaping products, health information about vaping has been somewhat unclear in regards to asso...
What is the current status of trial NCT05994209?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 189 participants. The study started on 2025-06-04. Estimated completion is 2026-06.
What conditions does trial NCT05994209 study?
This clinical trial studies the following conditions: Nicotine Use Disorder, Nicotine Vaping.
What interventions are being tested in trial NCT05994209?
The interventions under investigation include: quitSTART Mobile Application (DEVICE), Chatbot Feature in quitSTART Mobile Application (BEHAVIORAL).
Who is sponsoring clinical trial NCT05994209?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05994209 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Novel E-cigarette Constituents on Adults TCORS 3.0
RECRUITING · NA
-
Identify the Optimal TMS Pulse Protocol to Modulate Reward Activity
RECRUITING · NA
-
Identify the Optimal TMS Target to Modulate Reward Activity
RECRUITING · NA
-
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
RECRUITING · Phase 2
-
Temporal Interference Methods for Addiction Treatment
RECRUITING · NA
-
Families With Substance Use and Psychosis: A Pilot Study
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.